Cite
HARVARD Citation
Miyata, R. et al. (2022). Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment for postoperative recurrent EGFR-mutated lung adenocarcinoma: a multi-institutional retrospective study. European journal of cardio-thoracic surgery. p. . [Online].